KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Debt Ratio (2017 - 2020)

Xenon Pharmaceuticals (XENE) reported Debt Ratio of 0.07 for Q1 2020, down 49.96% year-over-year from 0.13 in Q2 2019, and down 37.14% on a QoQ basis from 0.11 in Q4 2019.

Xenon Pharmaceuticals (XENE) has 4 years of Debt Ratio data on file, last reported at 0.07 in Q1 2020.

  • Quarterly Debt Ratio fell 49.96% year-over-year to 0.07 in Q1 2020, while the trailing twelve-month figure through Mar 2020 was 0.07 (down 49.96% YoY) and the FY2019 annual result came in at 0.11, down 14.21% from the prior year.
  • Debt Ratio fell to 0.07 in Q1 2020 per XENE's latest filing, from 0.11 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.18 in Q1 2018 and bottomed at 0.07 in Q1 2020.
  • The 4-year median for Debt Ratio is 0.14 (2019), against an average of 0.13.
  • The widest annual swing landed in 2019, when Debt Ratio surged 36.47%; it then plunged 49.96% in 2020.
  • Tracing XENE's Debt Ratio over 4 years: stood at 0.15 in 2017, then fell by 16.87% to 0.12 in 2018, then slipped by 14.21% to 0.11 in 2019, then tumbled by 37.14% to 0.07 in 2020.
  • Per Business Quant, the three latest XENE Debt Ratio figures stand at 0.07 (Q1 2020), 0.11 (Q4 2019), and 0.16 (Q3 2019).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.18
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 1.41
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 0.05
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -
10 Xenon Pharmaceuticals 4.78 Bn 4.78 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2020 0.07
Dec 31, 2019 0.11
Sep 30, 2019 0.16
Jun 30, 2019 0.14
Mar 31, 2019 0.13
Dec 31, 2018 0.12
Sep 30, 2018 0.11
Jun 30, 2018 0.18
Mar 31, 2018 0.18
Dec 31, 2017 0.15